• Je něco špatně v tomto záznamu ?

Meis transcription factors regulate cardiac conduction system development and adult function

N. Muñoz-Martín, A. Simon-Chica, C. Díaz-Díaz, V. Cadenas, S. Temiño, I. Esteban, A. Ludwig, B. Schormair, J. Winkelmann, V. Olejnickova, D. Sedmera, D. Filgueiras-Rama, M. Torres

. 2025 ; 121 (2) : 311-323. [pub] 20250422

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25016063

Grantová podpora
SC1-BHC-07-2019 European Commission H2020 Program
Spanish
PGC2018-096486-B-I00 Ministerio de Ciencia e Innovación
P2022/BMD-7245 Comunidad de Madrid
the Ministry of Education, Youth and Sports
207029 of the Czech Republic
18-03461S Czech Science Foundation
100010434 'la Caixa' Foundation Severo Ochoa PhD Fellowship
7667 EMBO
CNIC
CEX2020-001041-S Ministerio de Ciencia e Innovación and the Pro CNIC Foundation

AIMS: The cardiac conduction system (CCS) is progressively specified during development by interactions among a discrete number of transcription factors (TFs) that ensure its proper patterning and the emergence of its functional properties. Meis genes encode homeodomain TFs with multiple roles in mammalian development. In humans, Meis genes associate with congenital cardiac malformations and alterations of cardiac electrical activity; however, the basis for these alterations has not been established. Here, we studied the role of Meis TFs in cardiomyocyte development and function during mouse development and adult life. METHODS AND RESULTS: We studied Meis1 and Meis2 conditional deletion mouse models that allowed cardiomyocyte-specific elimination of Meis function during development and inducible elimination of Meis function in cardiomyocytes of the adult CCS. We studied cardiac anatomy, contractility, and conduction. We report that Meis factors are global regulators of cardiac conduction, with a predominant role in the CCS. While constitutive Meis deletion in cardiomyocytes led to congenital malformations of the arterial pole and atria, as well as defects in ventricular conduction, Meis elimination in cardiomyocytes of the adult CCS produced sinus node dysfunction and delayed atrio-ventricular conduction. Molecular analyses unravelled Meis-controlled molecular pathways associated with these defects. Finally, we studied in transgenic mice the activity of a Meis1 human enhancer related to an single-nucleotide polymorphism (SNP) associated by Genome-wide association studies (GWAS) to PR (P and R waves of the electrocardiogram) elongation and found that the transgene drives expression in components of the atrio-ventricular conduction system. CONCLUSION: Our study identifies Meis TFs as essential regulators of the establishment of cardiac conduction function during development and its maintenance during adult life. In addition, we generated animal models and identified molecular alterations that will ease the study of Meis-associated conduction defects and congenital malformations in humans.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25016063
003      
CZ-PrNML
005      
20250731091456.0
007      
ta
008      
250708s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/cvr/cvae258 $2 doi
035    __
$a (PubMed)39691060
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Muñoz-Martín, Noelia $u Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain
245    10
$a Meis transcription factors regulate cardiac conduction system development and adult function / $c N. Muñoz-Martín, A. Simon-Chica, C. Díaz-Díaz, V. Cadenas, S. Temiño, I. Esteban, A. Ludwig, B. Schormair, J. Winkelmann, V. Olejnickova, D. Sedmera, D. Filgueiras-Rama, M. Torres
520    9_
$a AIMS: The cardiac conduction system (CCS) is progressively specified during development by interactions among a discrete number of transcription factors (TFs) that ensure its proper patterning and the emergence of its functional properties. Meis genes encode homeodomain TFs with multiple roles in mammalian development. In humans, Meis genes associate with congenital cardiac malformations and alterations of cardiac electrical activity; however, the basis for these alterations has not been established. Here, we studied the role of Meis TFs in cardiomyocyte development and function during mouse development and adult life. METHODS AND RESULTS: We studied Meis1 and Meis2 conditional deletion mouse models that allowed cardiomyocyte-specific elimination of Meis function during development and inducible elimination of Meis function in cardiomyocytes of the adult CCS. We studied cardiac anatomy, contractility, and conduction. We report that Meis factors are global regulators of cardiac conduction, with a predominant role in the CCS. While constitutive Meis deletion in cardiomyocytes led to congenital malformations of the arterial pole and atria, as well as defects in ventricular conduction, Meis elimination in cardiomyocytes of the adult CCS produced sinus node dysfunction and delayed atrio-ventricular conduction. Molecular analyses unravelled Meis-controlled molecular pathways associated with these defects. Finally, we studied in transgenic mice the activity of a Meis1 human enhancer related to an single-nucleotide polymorphism (SNP) associated by Genome-wide association studies (GWAS) to PR (P and R waves of the electrocardiogram) elongation and found that the transgene drives expression in components of the atrio-ventricular conduction system. CONCLUSION: Our study identifies Meis TFs as essential regulators of the establishment of cardiac conduction function during development and its maintenance during adult life. In addition, we generated animal models and identified molecular alterations that will ease the study of Meis-associated conduction defects and congenital malformations in humans.
650    _2
$a zvířata $7 D000818
650    12
$a transkripční faktor Meis1 $x genetika $x metabolismus $x nedostatek $7 D000075064
650    12
$a homeodoménové proteiny $x genetika $x metabolismus $7 D018398
650    12
$a kardiomyocyty $x metabolismus $x patologie $7 D032383
650    12
$a převodní systém srdeční $x metabolismus $x patofyziologie $x růst a vývoj $7 D006329
650    _2
$a myši knockoutované $7 D018345
650    _2
$a vývojová regulace genové exprese $7 D018507
650    _2
$a akční potenciály $7 D000200
650    12
$a srdeční frekvence $7 D006339
650    _2
$a fenotyp $7 D010641
650    _2
$a kontrakce myokardu $7 D009200
650    _2
$a srdeční arytmie $x patofyziologie $x metabolismus $x genetika $7 D001145
650    _2
$a vrozené srdeční vady $x metabolismus $x genetika $x patofyziologie $7 D006330
650    _2
$a věkové faktory $7 D000367
650    _2
$a nodus sinuatrialis $x metabolismus $x patofyziologie $7 D012849
655    _2
$a časopisecké články $7 D016428
700    1_
$a Simon-Chica, Ana $u Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $1 https://orcid.org/0000000206640397
700    1_
$a Díaz-Díaz, Covadonga $u Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $1 https://orcid.org/0000000320306456
700    1_
$a Cadenas, Vanessa $u Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $u Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 3-5 Av. Monforte de Lemos, Madrid 28029, Spain
700    1_
$a Temiño, Susana $u Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $u Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 3-5 Av. Monforte de Lemos, Madrid 28029, Spain
700    1_
$a Esteban, Isaac $u Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $1 https://orcid.org/0000000335301850
700    1_
$a Ludwig, Andreas $u Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, 17 Fahrstraße, Erlangen 91054, Germany
700    1_
$a Schormair, Barbara $u Institute of Neurogenomics, Helmholtz-Zentrum, 1 Ingolstädter Landstraße, Neuherberg 85764, Germany $1 https://orcid.org/0000000309425243
700    1_
$a Winkelmann, Juliane $u Institute of Neurogenomics, Helmholtz-Zentrum, 1 Ingolstädter Landstraße, Neuherberg 85764, Germany
700    1_
$a Olejnickova, Veronika $u First Faculty of Medicine, Institute of Anatomy, Charles University, U Nemocnice 3, Praha 2, 128 00, Czech Republic $1 https://orcid.org/0000000209911420 $7 mub2015894084
700    1_
$a Sedmera, David $u First Faculty of Medicine, Institute of Anatomy, Charles University, U Nemocnice 3, Praha 2, 128 00, Czech Republic $1 https://orcid.org/0000000268283671 $7 xx0037135
700    1_
$a Filgueiras-Rama, David $u Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $u Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 3-5 Av. Monforte de Lemos, Madrid 28029, Spain $u Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Calle del Prof Martín Lagos, Madrid 28040, Spain $1 https://orcid.org/0000000159092454
700    1_
$a Torres, Miguel $u Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $u Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 3-5 Av. Monforte de Lemos, Madrid 28029, Spain $1 https://orcid.org/0000000309064767
773    0_
$w MED00009440 $t Cardiovascular research $x 1755-3245 $g Roč. 121, č. 2 (2025), s. 311-323
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39691060 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731091450 $b ABA008
999    __
$a ok $b bmc $g 2366722 $s 1253188
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 121 $c 2 $d 311-323 $e 20250422 $i 1755-3245 $m Cardiovascular research $n Cardiovasc Res $x MED00009440
GRA    __
$a SC1-BHC-07-2019 $p European Commission H2020 Program
GRA    __
$p Spanish
GRA    __
$a PGC2018-096486-B-I00 $p Ministerio de Ciencia e Innovación
GRA    __
$a P2022/BMD-7245 $p Comunidad de Madrid
GRA    __
$p the Ministry of Education, Youth and Sports
GRA    __
$a 207029 $p of the Czech Republic
GRA    __
$a 18-03461S $p Czech Science Foundation
GRA    __
$a 100010434 $p 'la Caixa' Foundation Severo Ochoa PhD Fellowship
GRA    __
$a 7667 $p EMBO
GRA    __
$p CNIC
GRA    __
$a CEX2020-001041-S $p Ministerio de Ciencia e Innovación and the Pro CNIC Foundation
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...